Radiation and Chemotherapy

Radiation and Chemotherapy Review CME / CPD 

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:  Oncologists, Subspecialist Physicians, Family Practitioners, Internists, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Series 1-2B (RDC1-2B) Topics Include:  Targeted Treatment for HTB, Side Effects, Treatment for OPC, Rectal Cancer Treatment, Combining Radiation Therapy with Chemotherapy, and more. 

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Short Course:
RDC1-2B
Short Course Price:
$485
Format:
Available in Audio format.
Only Available Option: Short Course/Part B

Course Topics

Highlights from the 12th International Ultmann Chicago Lymphoma Symposium, Part 2

Compare and contrast chemotherapy and targeted treatment for patients with high-tumor burden (HTB) FL; Summarize the criteria for HTB and the prognostic index for FL; Recognize the possible benefit of radioimmunotherapy for patients with HTB FL; Identify useful prognostic markers in patients with CLL; Explain the importance of NOTCH1 mutations in CLL.

Radiotherapy for Head and Neck Cancers

Choose the appropriate treatment for patients with oropharyngeal cancer (OPC); Diagnose and treat desmoplastic neurotropic melanoma; Assess risk for locoregional failure in patients with head and neck melanoma; List the factors associated with longer overall survival in patients administered chemoradiation therapy for recurrent OPC; Consider re-irradiation in patients who have undergone surgical salvage for recurrent head and neck cancer.

Prostate Cancer 2016

Explain the benefit of adding docetaxel to androgen deprivation therapy (ADT) in the treatment of PC; Assess the effects of adding docetaxel to ADT plus external-beam radiation therapy in patients with high-risk PC; Recognize the positive immune response associated with the combination of radiation therapy and immunotherapy; Select appropriate candidates for intermittent hormonal therapy for PC;

Update on Colorectal Cancer

Treat patients with locally advanced rectal cancer according to the standard of care; Evaluate the role of short-course radiation therapy in the treatment of rectal cancer; Identify patients with metastatic colorectal cancer who are likely to benefit from locoregional therapy; Plan the management of locally advanced and recurrent rectal cancer; Apply the genomic analysis of colorectal cancer to clinical practice.

Radiation Oncology/Metastatic Renal Cell Carcinoma

Optimize treatment of cancer by combining radiation therapy with chemotherapy or targeted therapies; Consider new techniques for radiation therapy that minimize exposure to radiation and improve long-term outcomes; Identify patient factors that predict prognosis in metastatic renal cell carcinoma; Select systemic therapy for patients with renal cell carcinoma based on performance status, comorbidities, disease characteristics, and goals of treatment; Cite evidence on the potential role of immunotherapy in the treatment of metastatic renal cell carcinoma.

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include:  OrthopedicsTraumaSports Medicine and Multiple Sclerosis.

If you have taken the current Radiation and Chemotherapy CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.

For over 30 years, ASI has provided Continuing Medical Education, CME & CEU and Continuing Professional Development Education (CPD) for physicians and allied professionals in Radiation and Chemotherapy plus over 40 other specialties and subspecialties.  Lectures are recorded annually at the top seminars and conferences to provide the most current medical education to our clients.